Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

NCT07362446 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction
Reperfusion Injury
AMI
STEMI (ST Elevation MI)

Interventions

DRUG: Xolatryp
DRUG: Placebo

Sponsor

Nyrada Pty Ltd